The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: A pharmo study

Drugs and Aging

Volumn 20, Issue 11, 2003, Pages 833-839

  Panneman, Martien J M ^a   Goettsch, Wim G ^a   Kramarz, Piotr ^b   Herings, Ron M C ^a,c  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b Pfizer International   (Poland)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

ACCIDENT PREVENTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DATA ANALYSIS; DEMOGRAPHY; DRUG USE; FALLING; HUMAN; INJURY; MAJOR CLINICAL STUDY; NETHERLANDS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT;

ACCIDENTAL FALLS; AGED; BENZODIAZEPINES; EUROPEAN UNION; HEALTH EXPENDITURES; HIP FRACTURES; HOSPITALIZATION; HUMANS; PRESCRIPTIONS, DRUG; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 0141538303     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200320110-00004     Document Type: Article

References (25)

1. Herings RM, Stricker BH, de Boer A, et al. Benzodiazepines and the risk of falling leading to femur fractures: dosage more important than elimination half-life. Arch Intern Med 1995; 155 (16): 1801-7
2. Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf 2002; 11 (2): 97-104
3. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropoic drugs. J Am Geriatr Soc 1999; 47 (1): 30-9
4. Lindsay R. The burden of osteoporosis: cost. Am J Med 1995; 98 (2A): 9S-11S
5. Dolan P, Torgerson DJ. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 1998; 8 (6): 611-7
6. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12 (1): 24-35
7. Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med 1997; 103 (2A): 20S-5S
8. Koeck CM, Schwappach DL, Niemann FM, et al. Incidence and costs of osteoporosis-associated hip fractures in Austria. Wien Kiln Wochenschr 2001; 113 (10): 371-7
9. Reginster JY, Gillet P, Ben Sedrine W, et al. Direct costs of hip fractures in patients over 60 years of age in Belgium. Pharmacoeconomics 1999; 15 (5): 507-14
10. Herings RM, Klungel OH. An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in The Netherlands. Pharmacoeconomics 2001; 19 (6): 655-65
11. Coughlin SS, Benichou J, Weed DL. Attributable risk estimation in case-control studies. Epidemiol Rev 1994; 16 (1): 51-64
12. Herings RMC. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in The Netherlands [Doctorate]. Utrecht: Utrecht University, 1993
13. Paas GRA, Veenhuizen KCW. Onderzoek naar de betrouwbaarheid van de Landelijke Medische Registratie (LMR). Utrecht: Prismant, 2001
14. Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, et al. Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 2001; 54 (11): 1181-6
15. Miettinen OS. Theoretical epidemiology. Montreal: John Wiley & Sons Inc, 1985
16. OECD. OECD Health Data 2001. Paris: OECD Paris Centre, 2001
17. Logistic regression examples using the SAS system. Version 6. Cary (NC), USA: SAS Institute Inc, 1995
18. Lord SR, Anstey KJ, Williams P, et al. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol 1995; 39 (3): 227-34
19. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262 (23): 3303-7
20. Gorgels WJ, Oude Voshaar RC, Mol AJ, et al. [Long-term use of benzodiazepines]. Ned Tijdschr Geneeskd 2001; 145 (28): 1342-6
21. Bakker A. Drug use in the Netherlands, an introduction. In: Bakker A, Hekster YA, Leufkens HG, editors. Drug consumption in the Netherlands. Maarssen: Brocacef. 1991: 6-9
22. Boereboom FTJ, Raymakers JA, De Groot RRM, et al. Epidemiology of hip fractures in the Netherlands: women compared to men. Osteoporos Int 1992; 2:279-84
23. Kannus P, Niemi S, Parkkari J, et al. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999; 353 (9155): 802-5
24. Mazzuoli GF, Gennari C, Passeri M, et al. Hip fracture in Italy: epidemiology and preventive efficacy of bone-active drugs. Bone 1993; 14 Suppl. 1: S81-4
25. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157 (14): 1531-6